Based in Indianapolis, Indiana, Focus Surgery designs and manufactures the Sonablate® 500 system, an image-guided acoustic ablation device. Doctors worldwide have already successfully treated nearly 1,500 prostate cancer patients using the Sonablate® 500 and more than 1,500 BPH patients.
Focus Surgery maintains an internationally accredited Quality System which has achieved ISO 9001-2000 and ISO 13485-1996 certifications. The Sonablate® 500 has the CE Mark for the treatment of prostate diseases in Europe and MHW approval in Japan. The Sonablate® 500 is approved by the FDA as an investigational device for clinical trials in the United States.
The company has developed an extensive intellectual property portfolio with approved and pending patent applications, as well as partnerships with the leading clinical and scientific researchers from around the world. This research ensures that Focus Surgery will maintain it's position at the forefront of HIFU technology.
Focus Surgery and its employees are dedicated to improving the quality of care to patients with localized prostate disease, both benign and cancerous.
Focus Surgery, Inc.
3940 Pendleton Way
Indianapolis, IN 46226
USA
Tel: (317) 541-1580
Web: www.focus-surgery.com